Status:
COMPLETED
Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.
Lead Sponsor:
University Hospital, Angers
Conditions:
Mucositis Oral
Stem Cell Transplant Complications
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Chemotherapy-induced mucositis is an important complication after autologous stem cell transplantation. It is mainly responsible for pain and dysphagia requiring opioids and artificial nutrition. It c...
Eligibility Criteria
Inclusion
- Adult patients receiving autologous stem cell transplantation for lymphoma or myeloma.
- Signed informed consent.
Exclusion
- Autologous stem cell transplantation for another medical condition than lymphoma or myéloma.
- Intolerance to selenium.
- High selenium levels before study.
- Pregnancy or patients breast-feeding.
Key Trial Info
Start Date :
October 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04080622
Start Date
October 10 2019
End Date
October 31 2023
Last Update
December 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, Maine et Loire, France, 49933